Payment overview · 2025
General Payments
$379.98
20 reported records · 7 companies
Healthcare provider profile · identity verified
William E. Kirby, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BIRMINGHAM, AL · NPI 1750499844
Verified facts
What the public records show
CMS Open Payments records show William E. Kirby, M.D. received $379.98 in general payments during 2025 across 20 reported records.
GlaxoSmithKline, LLC. accounted for 36.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 11 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Myrbetriq by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 62 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 228 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $138.85 | 36.5% | 8 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $88.13 | 23.2% | 5 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $60.36 | 15.9% | 3 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $32.21 | 8.5% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.65 | 6.2% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.86 | 5.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.92 | 4.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $379.98 | 20 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $97.32 | 6 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $88.13 | 5 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $79.45 | 4 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $42.80 | 2 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $32.21 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $24.11 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $24.11 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $23.65 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $20.45 | 1 | 2025 |
Source payment records
|
|||||
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $18.86 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $17.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 62 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
35 | 13 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
62 | 13 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
228 | 46 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1251 | 371 |
| Amlodipine Besylate | Amlodipine Besylate | 865 | 262 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 803 | 177 |
| Levothyroxine Sodium | Levothyroxine Sodium | 778 | 208 |
| Pantoprazole Sodium | Pantoprazole Sodium | 656 | 182 |
| Gabapentin | Gabapentin | 607 | 132 |
| Lisinopril | Lisinopril | 428 | 126 |
| Losartan Potassium | Losartan Potassium | 405 | 137 |
| Alprazolam | Alprazolam | 402 | 83 |
| Ozempic | Semaglutide | 382 | 82 |
| Trazodone Hcl | Trazodone Hcl | 377 | 100 |
| Metoprolol Succinate | Metoprolol Succinate | 362 | 109 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 342 | 92 |
| Metformin Hcl | Metformin Hcl | 340 | 103 |
| Potassium Chloride | Potassium Chloride | 305 | 88 |
| Metformin Hcl Er | Metformin Hcl | 279 | 89 |
| Famotidine | Famotidine | 274 | 67 |
| Tramadol Hcl | Tramadol Hcl | 263 | 95 |
| Omeprazole | Omeprazole | 260 | 78 |
| Alendronate Sodium | Alendronate Sodium | 245 | 72 |
| Escitalopram Oxalate | Escitalopram Oxalate | 241 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 240 | 70 |
| Carvedilol | Carvedilol | 237 | 62 |
| Mounjaro | Tirzepatide | 236 | 46 |
| Eliquis | Apixaban | 228 | 46 |
| Furosemide | Furosemide | 226 | 81 |
| Pregabalin | Pregabalin | 226 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 223 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 218 | 65 |
| Tizanidine Hcl | Tizanidine Hcl | 211 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 206 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 203 | 65 |
| Lorazepam | Lorazepam | 189 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 183 | 62 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 182 | 34 |
| Clonazepam | Clonazepam | 178 | 35 |
| Montelukast Sodium | Montelukast Sodium | 175 | 47 |
| Jardiance | Empagliflozin | 173 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 168 | 26 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 166 | 57 |
| Hydrochlorothiazide | Hydrochlorothiazide | 160 | 51 |
| Allopurinol | Allopurinol | 154 | 54 |
| Simvastatin | Simvastatin | 153 | 44 |
| Atenolol | Atenolol | 147 | 41 |
| Sertraline Hcl | Sertraline Hcl | 146 | 46 |
| Quetiapine Fumarate | Quetiapine Fumarate | 138 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 137 | 46 |
| Donepezil Hcl | Donepezil Hcl | 136 | 38 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 129 | 40 |
| Glimepiride | Glimepiride | 122 | 31 |
| Mirtazapine | Mirtazapine | 121 | 37 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 112 | 28 |
| Spironolactone | Spironolactone | 112 | 34 |
| Trulicity | Dulaglutide | 112 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 50 |
| Ropinirole Hcl | Ropinirole Hcl | 102 | 20 |
| Meloxicam | Meloxicam | 101 | 26 |
| Lovastatin | Lovastatin | 100 | 30 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 91 | 27 |
| Januvia | Sitagliptin Phosphate | 90 | 23 |
| Memantine Hcl | Memantine Hcl | 87 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 84 | 26 |
| Buspirone Hcl | Buspirone Hcl | 83 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 83 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 81 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 79 | 37 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 77 | 29 |
| Ezetimibe | Ezetimibe | 76 | 22 |
| Linzess | Linaclotide | 76 | 18 |
| Sucralfate | Sucralfate | 76 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 74 | 28 |
| Estradiol | Estradiol | 73 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 70 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 67 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 66 | 44 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 65 | 14 |
| Levetiracetam | Levetiracetam | 62 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 19 |
| Meclizine Hcl | Meclizine Hcl | 61 | 24 |
| Temazepam | Temazepam | 61 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 60 | 15 |
| Baclofen | Baclofen | 58 | 15 |
| Finasteride | Finasteride | 57 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 14 |
| Midodrine Hcl | Midodrine Hcl | 53 | suppressed |
| Topiramate | Topiramate | 53 | 15 |
| Ondansetron Odt | Ondansetron | 52 | 24 |
| Colchicine | Colchicine | 50 | 26 |
| Prednisone | Prednisone | 50 | 14 |
| Clonidine Hcl | Clonidine Hcl | 49 | 19 |
| Verapamil Er | Verapamil Hcl | 48 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 47 | 11 |
| Labetalol Hcl | Labetalol Hcl | 47 | 12 |
| Methocarbamol | Methocarbamol | 47 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 47 | 32 |
| Amitriptyline Hcl | Amitriptyline Hcl | 42 | 14 |
| Diazepam | Diazepam | 42 | 11 |
| Valacyclovir | Valacyclovir Hcl | 41 | 15 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 39 | 14 |
| Bumetanide | Bumetanide | 38 | 16 |
| Doxepin Hcl | Doxepin Hcl | 38 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 38 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 38 | 12 |
| Cilostazol | Cilostazol | 37 | suppressed |
| Ranolazine Er | Ranolazine | 37 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 37 | 12 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 36 | 12 |
| Dutasteride | Dutasteride | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 27 |
| Myrbetriq | Mirabegron | 35 | 13 |
| Irbesartan | Irbesartan | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Lansoprazole | Lansoprazole | 33 | suppressed |
| Azithromycin | Azithromycin | 32 | 30 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | 11 |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | 11 |
| Klor-Con M20 | Potassium Chloride | 30 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 29 | 27 |
| Chlorthalidone | Chlorthalidone | 29 | 12 |
| Rizatriptan | Rizatriptan Benzoate | 29 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 28 | 11 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 28 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 28 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Celecoxib | Celecoxib | 26 | suppressed |
| Methimazole | Methimazole | 26 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 26 | 12 |
| Ziprasidone Hcl | Ziprasidone Hcl | 26 | suppressed |
| Belsomra | Suvorexant | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 25 | suppressed |
| Tradjenta | Linagliptin | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Nystatin | Nystatin | 24 | 13 |
| Prazosin Hcl | Prazosin Hcl | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | 11 |
| Ketoconazole | Ketoconazole | 23 | 16 |
| Mupirocin | Mupirocin | 23 | 11 |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 11 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 14 |
| Mometasone Furoate | Mometasone Furoate | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Febuxostat | Febuxostat | 14 | suppressed |
| Minoxidil | Minoxidil | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Victoza 2-Pak | Liraglutide | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Zonisamide | Zonisamide | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Oxazepam | Oxazepam | 11 | suppressed |
| Permethrin | Permethrin | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $379.98 · 20 records | GlaxoSmithKline, LLC. | ABRYSVO, AREXVY, COMIRNATY, Cologuard Collection Kit, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, KRYSTEXXA, PREVNAR 20, SHINGRIX, TRELEGY ELLIPTA, Veozah | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error